Serum Levels of Lipoxin A₄ do not Predict the Development of Subsequent Asthma among Young Children with Acute Bronchiolitis

References

• Boyce JA. Mechanisms of asthma and allergic inflammation. Mass Asthma 2005–2006: bench to bedside. J Allergy Clin Immunol 2006; 118:582–586.
   PubMedGoogle Scholar
• Everard ML. Acute bronchiolitis and croup. Pediatr Clin North Am 2009; 56:119–133.
   PubMedGoogle Scholar
• Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005; 172:824–830.
   PubMed Web of Science ®Google Scholar
• Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, Chanez P. Severe asthma is associated with a loss of LXA4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 2005; 115:55–60.
   PubMed Web of Science ®Google Scholar
• Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987; 79:939–945.
   PubMed Web of Science ®Google Scholar
• Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004; 3:401–416.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005; 3:41–162.
   Google Scholar
• McMahon B, Godson C. Lipoxins: endogenous regulators of inflammation. Am J Physiol 2004; 286:F189–201.
   PubMed Web of Science ®Google Scholar
• El Kebir D, Jozsef L, Filep JG. Opposing regulation of neutrophil apoptosis through the formyl peptid receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J Leukoc Biol 2008; 84(3):600–606.
   PubMedGoogle Scholar
• Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, Wang JM. A seven-trans-membrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999; 9:395–402.
   Google Scholar
• He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003; 1:1572–1581.
   Google Scholar
• Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. The lipoxin receptor ALX: potent ligand-specific and stereo-selective actions in vivo. Pharmacol Rev 2006; 8:463–487.
   Google Scholar
• Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008; 178:574–582.
   PubMed Web of Science ®Google Scholar
• Wu SH, Yin PL, Zhang YM, Tao HX. Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Pediatr Pulmonol 2010; 45:333–340.
   PubMed Web of Science ®Google Scholar
• Weinberger B, Quizon C, Vetrano AM, Archer F, Laskin JD, Laskin DL. Mechanisms mediating reduced responsiveness of neonatal neutrophils to Lipoxin A4. Pediatr Res 2008; 64:393–398.
   PubMedGoogle Scholar
• Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem 1997; 272:6972–6978.
   PubMed Web of Science ®Google Scholar
• Gronert K, Gewirtz A, Madara JL, Serhan CN. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha induced IL-8 release. J Exp Med 1998; 187:1285–1294.
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Gewirtz AT, Merlin D, Madara JL, Williams IR. Lateral membrane LXA4 receptors mediate LXA4’s anti-inflammatory actions on intestinal epithelium. Am J Physiol Cell Physiol 2003; 284:888–896.
   Google Scholar
• Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 2000; 164:2660–2666.
   PubMed Web of Science ®Google Scholar
• Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V. Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium. J Biol Chem 2003; 278:10879–10884.
   PubMedGoogle Scholar
• Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 2002; 165:1531–1535.
   PubMed Web of Science ®Google Scholar
• McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors. J Biol Chem 2000; 275:27566–27575.
   PubMedGoogle Scholar
• Levy BD, Lukacs NW, Berlin AA, Schmidt B, Guilford WJ, Serhan CN, Parkinson JF. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1receptor antagonism. FASEB J 2007; 21:3877–3884.
   PubMed Web of Science ®Google Scholar
• Takano T, Fiore S, Maddox JF, Schmidt B, Guilford WJ, Serhan CN, Parkinson JF. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 1997; 185:1693–1704.
   PubMed Web of Science ®Google Scholar
• Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005; 174:5033–5039.
   PubMed Web of Science ®Google Scholar
• Chiang N, Hurwitz S, Ridker PM, Serhan CN. Aspirin has a gender-dependent impact on anti-inflammatory 15-epi-lipoxinA4 formation: a randomized human trial. Arterioscler Thromb Vasc Biol 2006; 26:e14–e17.
   Web of Science ®Google Scholar
• Bonnans C, Chanez P, Chavis C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004; 59:1027–1041.
   PubMedGoogle Scholar
• Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase-2-NSAIDs and trans-cellular processing. J Exp Med 2000; 192:1197–1204.
   PubMed Web of Science ®Google Scholar